SEC EDGAR filings, ownership reports, and insider transactions for Universe Pharmaceuticals INC.
Recent SEC filings for Universe Pharmaceuticals INC including 6-K, 20-F, SCHEDULE 13G/A and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 11 Feb 2026 | 11 Feb 2026 | 001-40231 |
| 20-F | Open 20-F document | Open XBRL data | View SEC filing for 20-F | ANNUAL REPORT | 29 Jan 2026 | 30 Sep 2025 | 001-40231 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 07 Jan 2026 | 005-93205 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 03 Sep 2025 | 03 Sep 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 26 Aug 2025 | 26 Aug 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 29 Jul 2025 | 29 Jul 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 03 Jul 2025 | 03 Jul 2025 | 001-40231 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 15 May 2025 | 005-93205 | ||
| 20-F | Open 20-F document | Open XBRL data | View SEC filing for 20-F | ANNUAL REPORT | 29 Apr 2025 | 30 Sep 2024 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 20 Mar 2025 | 20 Mar 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 11 Mar 2025 | 11 Mar 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 03 Mar 2025 | 03 Mar 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 25 Feb 2025 | 25 Feb 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 20 Feb 2025 | 20 Feb 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 18 Feb 2025 | 18 Feb 2025 | 001-40231 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 14 Feb 2025 | 005-93205 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT | 11 Feb 2025 | 11 Feb 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 03 Feb 2025 | 03 Feb 2025 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT | 30 Jan 2025 | 30 Jan 2025 | 001-40231 |
| NT 20-F | Open NT 20-F document | View SEC filing for NT 20-F | NOTIFICATION OF LATE FILING | 27 Jan 2025 | 30 Sep 2024 | 001-40231 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 03 Jan 2025 | 005-93205 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 12 Dec 2024 | 12 Dec 2024 | 001-40231 |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | PROSPECTUS SUPPLEMENT | 09 Dec 2024 | 333-268028 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 13 Nov 2024 | 13 Nov 2024 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 01 Nov 2024 | 01 Nov 2024 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 10 Oct 2024 | 10 Oct 2024 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 27 Sep 2024 | 27 Sep 2024 | 001-40231 |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 20 Sep 2024 | 31 Mar 2024 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT | 03 Sep 2024 | 03 Sep 2024 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 18 Jul 2024 | 18 Jul 2024 | 001-40231 |
| 424B4 | Open 424B4 document | View SEC filing for 424B4 | PROSPECTUS | 25 Jun 2024 | 333-278914 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 07 Jun 2024 | 333-278914 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 05 Jun 2024 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 14 May 2024 | |||
| F-1/A | Open F-1/A document | View SEC filing for F-1/A | AMENDMENT NO. 1 TO FORM F-1 | 14 May 2024 | 333-278914 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 08 May 2024 | 333-278914 | ||
| F-1 | Open F-1 document | View SEC filing for F-1 | REGISTRATION STATEMENT | 24 Apr 2024 | 333-278914 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 07 Feb 2024 | 07 Feb 2024 | 001-40231 |
| 20-F | Open 20-F document | Open XBRL data | View SEC filing for 20-F | ANNUAL REPORT | 30 Jan 2024 | 30 Sep 2023 | 001-40231 |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 31 Aug 2023 | 31 Mar 2023 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 16 Aug 2023 | 16 Aug 2023 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 04 Aug 2023 | 04 Aug 2023 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 27 Jul 2023 | 27 Jul 2023 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 05 Jul 2023 | 05 Jul 2023 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT | 24 May 2023 | 24 May 2023 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 05 May 2023 | 05 May 2023 | 001-40231 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Feb 2023 | 005-93205 | ||
| 20-F | Open 20-F document | Open XBRL data | View SEC filing for 20-F | ANNUAL REPORT | 10 Feb 2023 | 30 Sep 2022 | 001-40231 |
| NT 20-F | Open NT 20-F document | View SEC filing for NT 20-F | NOTIFICATION OF LATE FILING | 30 Jan 2023 | 30 Sep 2022 | 001-40231 |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 15 Nov 2022 | 333-268028 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 14 Nov 2022 | 14 Nov 2022 | 001-40231 |
| F-3 | Open F-3 document | View SEC filing for F-3 | REGISTRATION STATEMENT | 27 Oct 2022 | 333-268028 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 28 Sep 2022 | 28 Sep 2022 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 29 Aug 2022 | 29 Aug 2022 | 001-40231 |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 16 Aug 2022 | 31 Mar 2022 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 19 Jul 2022 | 19 Jul 2022 | 001-40231 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SCHEDULE 13G | 11 Feb 2022 | 005-93205 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 31 Jan 2022 | 31 Jan 2022 | 001-40231 |
| 20-F | Open 20-F document | Open XBRL data | View SEC filing for 20-F | ANNUAL REPORT | 31 Jan 2022 | 30 Sep 2021 | 001-40231 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | UPC PURA VIDA 13G | 28 Dec 2021 | 005-93205 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 15 Dec 2021 | 15 Dec 2021 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 10 Dec 2021 | 10 Dec 2021 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 09 Dec 2021 | 09 Dec 2021 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 02 Aug 2021 | 02 Aug 2021 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT | 31 Mar 2021 | 31 Mar 2021 | 001-40231 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 25 Mar 2021 | 25 Mar 2021 | 001-40231 |
| 424B4 | Open 424B4 document | View SEC filing for 424B4 | PROSPECTUS | 24 Mar 2021 | 333-248067 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 22 Mar 2021 | 333-248067 | ||
| CERT | Open CERT document | View SEC filing for CERT | 22 Mar 2021 | 001-40231 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 17 Mar 2021 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 17 Mar 2021 | |||
| 8-A12B | Open 8-A12B document | View SEC filing for 8-A12B | FORM 8-A12B | 17 Mar 2021 | 001-40231 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 10 Mar 2021 | |||
| F-1/A | Open F-1/A document | View SEC filing for F-1/A | AMENDMENT NO. 4 TO FORM F-1 | 10 Mar 2021 | 333-248067 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 02 Mar 2021 | |||
| FWP | Open FWP document | View SEC filing for FWP | FREE WRITING PROSPECTUS | 01 Mar 2021 | 333-248067 | |
| FWP | Open FWP document | View SEC filing for FWP | FREE WRITING PROSPECTUS | 01 Mar 2021 | 333-248067 | |
| F-1/A | Open F-1/A document | View SEC filing for F-1/A | AMENDMENT NO. 3 TO FORM F-1 | 24 Feb 2021 | 333-248067 | |
| FWP | Open FWP document | View SEC filing for FWP | FREE WRITING PROSPECTUS | 10 Dec 2020 | 333-248067 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 02 Dec 2020 | |||
| F-1/A | Open F-1/A document | View SEC filing for F-1/A | AMENDMENT NO.2 TO FORM F-1 | 02 Dec 2020 | 333-248067 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 19 Nov 2020 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 17 Nov 2020 | |||
| F-1/A | Open F-1/A document | View SEC filing for F-1/A | AMENDMENT NO. 1 TO FORM F-1 | 17 Nov 2020 | 333-248067 | |
| FWP | Open FWP document | View SEC filing for FWP | FREE WRITING PROSPECTUS | 23 Sep 2020 | 333-248067 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 01 Sep 2020 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 17 Aug 2020 | |||
| F-1 | Open F-1 document | View SEC filing for F-1 | REGISTRATION STATEMENT | 17 Aug 2020 | 333-248067 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 24 Jun 2020 | |||
| DRSLTR | Open DRSLTR document | View SEC filing for DRSLTR | 12 Jun 2020 | |||
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 12 Jun 2020 | 377-03139 | ||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 20 May 2020 | |||
| DRS | Open DRS document | View SEC filing for DRS | 24 Apr 2020 | 377-03139 |
Universe Pharmaceuticals INC files with the SEC under CIK 0001809616. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.